Delivery Order SPE2DB24D1205-SPE2DB24FCSRM
Award Date
7/11/24
Potential Completion Date
8/1/24
Potential Value
$9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ZEPZELCA 4 MG VIALS. The $9,025.76 firm-fixed-price delivery order has a completion date of November 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The $9,025.76 Firm Fixed Price contract is for the supply of 4,565,122,173 units of the drug ZEPZELCA 4 MG VIALS. This award is part of a larger Indefinite Delivery Contract between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $9,025.76 firm fixed price delivery order is for the supply of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up...
This contract award, valued at $9,565.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPZELCA 4 MG VIALS, a specialty medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $1,393.14 firm fixed-price contract is for the supply of the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML." This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which enables DLA to efficiently...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $14,305.38 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. This contract is a part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. Under this larger IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical...
This federal contract award is a delivery order valued at $7,745.38 for the pharmaceutical product ZEPBOUND 10 MG/0.5 ML PEN 0.5ML. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price, non-set-aside vehicle with a performance period through May 30, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $25,549.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $9,085.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a $13,627.38 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC enables the company to provide a comprehensive range of pharmaceutical products and medical supplies, including...